CR

Christophe Ricard

Europe, Geneve, Switzerland, Geneva

Description

Christophe Ricard CEO of OM Pharma

Investor Profile

Christophe Ricard has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Seed rounds (top funding stages).
  • Majority of deals are located in France.
  • Strong thematic focus on Biotechnology, Life Science, Medical Device.

Stage Focus

  • Series B (50%)
  • Seed (50%)

Country Focus

  • France (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Christophe Ricard frequently co-invest with?

AMR Action Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Turenne Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
IRDI SORIDEC Gestion
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Christophe Ricard?

Antabio

Labège, Midi-Pyrenees, France

Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

BiotechnologyLife ScienceMedical Device
Series BDec 12, 2023
Amount Raised: $26,996,237
Antabio

Labège, Midi-Pyrenees, France

Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

BiotechnologyLife ScienceMedical Device
SeedJan 12, 2012

Find More Investors Like Christophe Ricard

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Christophe Ricard | Pipeseed